ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Oral Presentation
Chairs: W. Randerath (Solingen, Germany), J. Pépin (Grenoble, France)

Late Breaking Abstract - Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study_Update J. Pépin (Grenoble, France)
Distinguishing Patients with Central from Obstructive Sleep Apnea Using Overnight Breath Sound Recordings H. Alshaer (Toronto, ON, Canada)
Loop Gain in Heart Failure Patients with Periodic Breathing S. Herkenrath (Solingen, Germany)
Association of obstructive sleep apnoea but not central sleep apnoea and spheric remodeling of left ventricle in patients with ST-segment elevation anterior myocardial infarction C. Fisser (REGENSBURG, Germany)
Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA). O. Krakhmalova (Kharkiv, Ukraine)
Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA) C. Gunduz (Izmir, Turkey)
OSA and cancer in Europe: the European Sleep Apnea Database (ESADA) experience A. Pataka (Thessaloniki, Greece)
CPAP appears to protect kidney function of patients with OSA. J. Wingfield Digby (Manchester, United Kingdom)